The global Recombinant Human Oncostatin M (OSM) Protein market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2023, While China is Forecast to Reach $ Million.
?80% Segment to Reach $ Million by 2030, with a % CAGR in next six years.
The global key manufacturers of Recombinant Human Oncostatin M (OSM) Protein include R&D Systems, Abcam, Qkine, Elabscience, Kingfisher Biotech, ZellBio GmbH, Sino Biological, enQuire BioReagents and Novus Biologicals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
This report aims to provide a comprehensive presentation of the global market for Recombinant Human Oncostatin M (OSM) Protein, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Oncostatin M (OSM) Protein. This report contains market size and forecasts of Recombinant Human Oncostatin M (OSM) Protein in global, including the following market information:
Global Recombinant Human Oncostatin M (OSM) Protein Market Revenue, 2019-2024, 2025-2030, ($ millions)
Global Recombinant Human Oncostatin M (OSM) Protein Market Sales, 2019-2024, 2025-2030, (Tons)
Global top five Recombinant Human Oncostatin M (OSM) Protein companies in 2023 (%)
We surveyed the Recombinant Human Oncostatin M (OSM) Protein manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Recombinant Human Oncostatin M (OSM) Protein Market, by Purity, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Recombinant Human Oncostatin M (OSM) Protein Market Segment Percentages, by Purity, 2023 (%)
?80%
?95%
?97%
Others
Global Recombinant Human Oncostatin M (OSM) Protein Market, by Application, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Recombinant Human Oncostatin M (OSM) Protein Market Segment Percentages, by Application, 2023 (%)
ELISA
WB
Cell Culture
Others
Global Recombinant Human Oncostatin M (OSM) Protein Market, By Region and Country, 2019-2024, 2025-2030 ($ Millions) & (Tons)
Global Recombinant Human Oncostatin M (OSM) Protein Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Recombinant Human Oncostatin M (OSM) Protein revenues in global market, 2019-2024 (Estimated), ($ millions)
Key companies Recombinant Human Oncostatin M (OSM) Protein revenues share in global market, 2023 (%)
Key companies Recombinant Human Oncostatin M (OSM) Protein sales in global market, 2019-2024 (Estimated), (Tons)
Key companies Recombinant Human Oncostatin M (OSM) Protein sales share in global market, 2023 (%)
Further, the report presents profiles of competitors in the market, key players include:
R&D Systems
Abcam
Qkine
Elabscience
Kingfisher Biotech
ZellBio GmbH
Sino Biological
enQuire BioReagents
Novus Biologicals
PeproTech
Cell Guidance Systems
Thermo Fisher
Abbexa
Cusabio
BioLegend
Assay Genie
Boster Bio
OriGene
Universal Biologicals
St John's Laboratory
RayBiotech
Lifespan Biosciences
Outline of Major Chapters:
Chapter 1: Introduces the definition of Recombinant Human Oncostatin M (OSM) Protein, market overview.
Chapter 2: Global Recombinant Human Oncostatin M (OSM) Protein market size in revenue and volume.
Chapter 3: Detailed analysis of Recombinant Human Oncostatin M (OSM) Protein manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by purity, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Recombinant Human Oncostatin M (OSM) Protein in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Recombinant Human Oncostatin M (OSM) Protein capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Recombinant Human Oncostatin M (OSM) Protein Market Definition
1.2 Market Segments
1.2.1 Market by Purity
1.2.2 Market by Application
1.3 Global Recombinant Human Oncostatin M (OSM) Protein Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Recombinant Human Oncostatin M (OSM) Protein Overall Market Size
2.1 Global Recombinant Human Oncostatin M (OSM) Protein Market Size: 2023 VS 2030
2.2 Global Recombinant Human Oncostatin M (OSM) Protein Revenue, Prospects & Forecasts: 2019-2030
2.3 Global Recombinant Human Oncostatin M (OSM) Protein Sales: 2019-2030
3 Company Landscape
3.1 Top Recombinant Human Oncostatin M (OSM) Protein Players in Global Market
3.2 Top Global Recombinant Human Oncostatin M (OSM) Protein Companies Ranked by Revenue
3.3 Global Recombinant Human Oncostatin M (OSM) Protein Revenue by Companies
3.4 Global Recombinant Human Oncostatin M (OSM) Protein Sales by Companies
3.5 Global Recombinant Human Oncostatin M (OSM) Protein Price by Manufacturer (2019-2024)
3.6 Top 3 and Top 5 Recombinant Human Oncostatin M (OSM) Protein Companies in Global Market, by Revenue in 2023
3.7 Global Manufacturers Recombinant Human Oncostatin M (OSM) Protein Product Type
3.8 Tier 1, Tier 2 and Tier 3 Recombinant Human Oncostatin M (OSM) Protein Players in Global Market
3.8.1 List of Global Tier 1 Recombinant Human Oncostatin M (OSM) Protein Companies
3.8.2 List of Global Tier 2 and Tier 3 Recombinant Human Oncostatin M (OSM) Protein Companies
4 Sights by Product
4.1 Overview
4.1.1 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Market Size Markets, 2023 & 2030
4.1.2 ?80%
4.1.3 ?95%
4.1.4 ?97%
4.1.5 Others
4.2 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue & Forecasts
4.2.1 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2024
4.2.2 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2025-2030
4.2.3 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
4.3 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales & Forecasts
4.3.1 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2024
4.3.2 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2025-2030
4.3.3 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
4.4 By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Market Size, 2023 & 2030
5.1.2 ELISA
5.1.3 WB
5.1.4 Cell Culture
5.1.5 Others
5.2 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue & Forecasts
5.2.1 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2024
5.2.2 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2025-2030
5.2.3 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
5.3 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales & Forecasts
5.3.1 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2024
5.3.2 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2025-2030
5.3.3 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
5.4 By Application - Global Recombinant Human Oncostatin M (OSM) Protein Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
6.1 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Market Size, 2023 & 2030
6.2 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue & Forecasts
6.2.1 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2024
6.2.2 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2025-2030
6.2.3 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
6.3 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales & Forecasts
6.3.1 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2024
6.3.2 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales, 2025-2030
6.3.3 By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
6.4 North America
6.4.1 By Country - North America Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030
6.4.2 By Country - North America Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2030
6.4.3 US Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.4.4 Canada Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.4.5 Mexico Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5 Europe
6.5.1 By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030
6.5.2 By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2030
6.5.3 Germany Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.4 France Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.5 U.K. Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.6 Italy Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.7 Russia Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.8 Nordic Countries Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.5.9 Benelux Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.6 Asia
6.6.1 By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030
6.6.2 By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2030
6.6.3 China Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.6.4 Japan Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.6.5 South Korea Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.6.6 Southeast Asia Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.6.7 India Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.7 South America
6.7.1 By Country - South America Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030
6.7.2 By Country - South America Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2030
6.7.3 Brazil Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.7.4 Argentina Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030
6.8.2 By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Sales, 2019-2030
6.8.3 Turkey Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.8.4 Israel Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.8.5 Saudi Arabia Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
6.8.6 UAE Recombinant Human Oncostatin M (OSM) Protein Market Size, 2019-2030
7 Manufacturers & Brands Profiles
7.1 R&D Systems
7.1.1 R&D Systems Company Summary
7.1.2 R&D Systems Business Overview
7.1.3 R&D Systems Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.1.4 R&D Systems Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.1.5 R&D Systems Key News & Latest Developments
7.2 Abcam
7.2.1 Abcam Company Summary
7.2.2 Abcam Business Overview
7.2.3 Abcam Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.2.4 Abcam Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.2.5 Abcam Key News & Latest Developments
7.3 Qkine
7.3.1 Qkine Company Summary
7.3.2 Qkine Business Overview
7.3.3 Qkine Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.3.4 Qkine Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.3.5 Qkine Key News & Latest Developments
7.4 Elabscience
7.4.1 Elabscience Company Summary
7.4.2 Elabscience Business Overview
7.4.3 Elabscience Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.4.4 Elabscience Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.4.5 Elabscience Key News & Latest Developments
7.5 Kingfisher Biotech
7.5.1 Kingfisher Biotech Company Summary
7.5.2 Kingfisher Biotech Business Overview
7.5.3 Kingfisher Biotech Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.5.4 Kingfisher Biotech Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.5.5 Kingfisher Biotech Key News & Latest Developments
7.6 ZellBio GmbH
7.6.1 ZellBio GmbH Company Summary
7.6.2 ZellBio GmbH Business Overview
7.6.3 ZellBio GmbH Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.6.4 ZellBio GmbH Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.6.5 ZellBio GmbH Key News & Latest Developments
7.7 Sino Biological
7.7.1 Sino Biological Company Summary
7.7.2 Sino Biological Business Overview
7.7.3 Sino Biological Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.7.4 Sino Biological Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.7.5 Sino Biological Key News & Latest Developments
7.8 enQuire BioReagents
7.8.1 enQuire BioReagents Company Summary
7.8.2 enQuire BioReagents Business Overview
7.8.3 enQuire BioReagents Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.8.4 enQuire BioReagents Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.8.5 enQuire BioReagents Key News & Latest Developments
7.9 Novus Biologicals
7.9.1 Novus Biologicals Company Summary
7.9.2 Novus Biologicals Business Overview
7.9.3 Novus Biologicals Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.9.4 Novus Biologicals Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.9.5 Novus Biologicals Key News & Latest Developments
7.10 PeproTech
7.10.1 PeproTech Company Summary
7.10.2 PeproTech Business Overview
7.10.3 PeproTech Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.10.4 PeproTech Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.10.5 PeproTech Key News & Latest Developments
7.11 Cell Guidance Systems
7.11.1 Cell Guidance Systems Company Summary
7.11.2 Cell Guidance Systems Recombinant Human Oncostatin M (OSM) Protein Business Overview
7.11.3 Cell Guidance Systems Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.11.4 Cell Guidance Systems Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.11.5 Cell Guidance Systems Key News & Latest Developments
7.12 Thermo Fisher
7.12.1 Thermo Fisher Company Summary
7.12.2 Thermo Fisher Recombinant Human Oncostatin M (OSM) Protein Business Overview
7.12.3 Thermo Fisher Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.12.4 Thermo Fisher Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.12.5 Thermo Fisher Key News & Latest Developments
7.13 Abbexa
7.13.1 Abbexa Company Summary
7.13.2 Abbexa Recombinant Human Oncostatin M (OSM) Protein Business Overview
7.13.3 Abbexa Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.13.4 Abbexa Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.13.5 Abbexa Key News & Latest Developments
7.14 Cusabio
7.14.1 Cusabio Company Summary
7.14.2 Cusabio Business Overview
7.14.3 Cusabio Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.14.4 Cusabio Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.14.5 Cusabio Key News & Latest Developments
7.15 BioLegend
7.15.1 BioLegend Company Summary
7.15.2 BioLegend Business Overview
7.15.3 BioLegend Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.15.4 BioLegend Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.15.5 BioLegend Key News & Latest Developments
7.16 Assay Genie
7.16.1 Assay Genie Company Summary
7.16.2 Assay Genie Business Overview
7.16.3 Assay Genie Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.16.4 Assay Genie Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.16.5 Assay Genie Key News & Latest Developments
7.17 Boster Bio
7.17.1 Boster Bio Company Summary
7.17.2 Boster Bio Business Overview
7.17.3 Boster Bio Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.17.4 Boster Bio Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.17.5 Boster Bio Key News & Latest Developments
7.18 OriGene
7.18.1 OriGene Company Summary
7.18.2 OriGene Business Overview
7.18.3 OriGene Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.18.4 OriGene Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.18.5 OriGene Key News & Latest Developments
7.19 Universal Biologicals
7.19.1 Universal Biologicals Company Summary
7.19.2 Universal Biologicals Business Overview
7.19.3 Universal Biologicals Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.19.4 Universal Biologicals Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.19.5 Universal Biologicals Key News & Latest Developments
7.20 St John's Laboratory
7.20.1 St John's Laboratory Company Summary
7.20.2 St John's Laboratory Business Overview
7.20.3 St John's Laboratory Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.20.4 St John's Laboratory Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.20.5 St John's Laboratory Key News & Latest Developments
7.21 RayBiotech
7.21.1 RayBiotech Company Summary
7.21.2 RayBiotech Business Overview
7.21.3 RayBiotech Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.21.4 RayBiotech Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.21.5 RayBiotech Key News & Latest Developments
7.22 Lifespan Biosciences
7.22.1 Lifespan Biosciences Company Summary
7.22.2 Lifespan Biosciences Business Overview
7.22.3 Lifespan Biosciences Recombinant Human Oncostatin M (OSM) Protein Major Product Offerings
7.22.4 Lifespan Biosciences Recombinant Human Oncostatin M (OSM) Protein Sales and Revenue in Global (2019-2024)
7.22.5 Lifespan Biosciences Key News & Latest Developments
8 Global Recombinant Human Oncostatin M (OSM) Protein Production Capacity, Analysis
8.1 Global Recombinant Human Oncostatin M (OSM) Protein Production Capacity, 2019-2030
8.2 Recombinant Human Oncostatin M (OSM) Protein Production Capacity of Key Manufacturers in Global Market
8.3 Global Recombinant Human Oncostatin M (OSM) Protein Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Recombinant Human Oncostatin M (OSM) Protein Supply Chain Analysis
10.1 Recombinant Human Oncostatin M (OSM) Protein Industry Value Chain
10.2 Recombinant Human Oncostatin M (OSM) Protein Upstream Market
10.3 Recombinant Human Oncostatin M (OSM) Protein Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Recombinant Human Oncostatin M (OSM) Protein Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Recombinant Human Oncostatin M (OSM) Protein in Global Market
Table 2. Top Recombinant Human Oncostatin M (OSM) Protein Players in Global Market, Ranking by Revenue (2023)
Table 3. Global Recombinant Human Oncostatin M (OSM) Protein Revenue by Companies, (US$, Mn), 2019-2024
Table 4. Global Recombinant Human Oncostatin M (OSM) Protein Revenue Share by Companies, 2019-2024
Table 5. Global Recombinant Human Oncostatin M (OSM) Protein Sales by Companies, (Tons), 2019-2024
Table 6. Global Recombinant Human Oncostatin M (OSM) Protein Sales Share by Companies, 2019-2024
Table 7. Key Manufacturers Recombinant Human Oncostatin M (OSM) Protein Price (2019-2024) & (US$/Ton)
Table 8. Global Manufacturers Recombinant Human Oncostatin M (OSM) Protein Product Type
Table 9. List of Global Tier 1 Recombinant Human Oncostatin M (OSM) Protein Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Recombinant Human Oncostatin M (OSM) Protein Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Purity ? Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 & 2030
Table 12. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2019-2024
Table 13. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2025-2030
Table 14. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2019-2024
Table 15. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2025-2030
Table 16. By Application ? Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 & 2030
Table 17. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2019-2024
Table 18. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2025-2030
Table 19. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2019-2024
Table 20. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2025-2030
Table 21. By Region ? Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 VS 2030
Table 22. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2019-2024
Table 23. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue (US$, Mn), 2025-2030
Table 24. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2019-2024
Table 25. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), 2025-2030
Table 26. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2024
Table 27. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2025-2030
Table 28. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2019-2024
Table 29. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2025-2030
Table 30. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2024
Table 31. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2025-2030
Table 32. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2019-2024
Table 33. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2025-2030
Table 34. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2024
Table 35. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2025-2030
Table 36. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2019-2024
Table 37. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2025-2030
Table 38. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2024
Table 39. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2025-2030
Table 40. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2019-2024
Table 41. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2025-2030
Table 42. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2024
Table 43. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2025-2030
Table 44. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2019-2024
Table 45. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Sales, (Tons), 2025-2030
Table 46. R&D Systems Company Summary
Table 47. R&D Systems Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 48. R&D Systems Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 49. R&D Systems Key News & Latest Developments
Table 50. Abcam Company Summary
Table 51. Abcam Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 52. Abcam Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 53. Abcam Key News & Latest Developments
Table 54. Qkine Company Summary
Table 55. Qkine Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 56. Qkine Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 57. Qkine Key News & Latest Developments
Table 58. Elabscience Company Summary
Table 59. Elabscience Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 60. Elabscience Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 61. Elabscience Key News & Latest Developments
Table 62. Kingfisher Biotech Company Summary
Table 63. Kingfisher Biotech Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 64. Kingfisher Biotech Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 65. Kingfisher Biotech Key News & Latest Developments
Table 66. ZellBio GmbH Company Summary
Table 67. ZellBio GmbH Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 68. ZellBio GmbH Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 69. ZellBio GmbH Key News & Latest Developments
Table 70. Sino Biological Company Summary
Table 71. Sino Biological Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 72. Sino Biological Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 73. Sino Biological Key News & Latest Developments
Table 74. enQuire BioReagents Company Summary
Table 75. enQuire BioReagents Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 76. enQuire BioReagents Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 77. enQuire BioReagents Key News & Latest Developments
Table 78. Novus Biologicals Company Summary
Table 79. Novus Biologicals Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 80. Novus Biologicals Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 81. Novus Biologicals Key News & Latest Developments
Table 82. PeproTech Company Summary
Table 83. PeproTech Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 84. PeproTech Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 85. PeproTech Key News & Latest Developments
Table 86. Cell Guidance Systems Company Summary
Table 87. Cell Guidance Systems Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 88. Cell Guidance Systems Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 89. Cell Guidance Systems Key News & Latest Developments
Table 90. Thermo Fisher Company Summary
Table 91. Thermo Fisher Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 92. Thermo Fisher Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 93. Thermo Fisher Key News & Latest Developments
Table 94. Abbexa Company Summary
Table 95. Abbexa Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 96. Abbexa Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 97. Abbexa Key News & Latest Developments
Table 98. Cusabio Company Summary
Table 99. Cusabio Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 100. Cusabio Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 101. Cusabio Key News & Latest Developments
Table 102. BioLegend Company Summary
Table 103. BioLegend Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 104. BioLegend Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 105. BioLegend Key News & Latest Developments
Table 106. Assay Genie Company Summary
Table 107. Assay Genie Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 108. Assay Genie Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 109. Assay Genie Key News & Latest Developments
Table 110. Boster Bio Company Summary
Table 111. Boster Bio Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 112. Boster Bio Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 113. Boster Bio Key News & Latest Developments
Table 114. OriGene Company Summary
Table 115. OriGene Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 116. OriGene Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 117. OriGene Key News & Latest Developments
Table 118. Universal Biologicals Company Summary
Table 119. Universal Biologicals Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 120. Universal Biologicals Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 121. Universal Biologicals Key News & Latest Developments
Table 122. St John's Laboratory Company Summary
Table 123. St John's Laboratory Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 124. St John's Laboratory Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 125. St John's Laboratory Key News & Latest Developments
Table 126. RayBiotech Company Summary
Table 127. RayBiotech Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 128. RayBiotech Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 129. RayBiotech Key News & Latest Developments
Table 130. Lifespan Biosciences Company Summary
Table 131. Lifespan Biosciences Recombinant Human Oncostatin M (OSM) Protein Product Offerings
Table 132. Lifespan Biosciences Recombinant Human Oncostatin M (OSM) Protein Sales (Tons), Revenue (US$, Mn) and Average Price (US$/Ton) (2019-2024)
Table 133. Lifespan Biosciences Key News & Latest Developments
Table 134. Recombinant Human Oncostatin M (OSM) Protein Production Capacity (Tons) of Key Manufacturers in Global Market, 2021-2024 (Tons)
Table 135. Global Recombinant Human Oncostatin M (OSM) Protein Capacity Market Share of Key Manufacturers, 2021-2024
Table 136. Global Recombinant Human Oncostatin M (OSM) Protein Production by Region, 2019-2024 (Tons)
Table 137. Global Recombinant Human Oncostatin M (OSM) Protein Production by Region, 2025-2030 (Tons)
Table 138. Recombinant Human Oncostatin M (OSM) Protein Market Opportunities & Trends in Global Market
Table 139. Recombinant Human Oncostatin M (OSM) Protein Market Drivers in Global Market
Table 140. Recombinant Human Oncostatin M (OSM) Protein Market Restraints in Global Market
Table 141. Recombinant Human Oncostatin M (OSM) Protein Raw Materials
Table 142. Recombinant Human Oncostatin M (OSM) Protein Raw Materials Suppliers in Global Market
Table 143. Typical Recombinant Human Oncostatin M (OSM) Protein Downstream
Table 144. Recombinant Human Oncostatin M (OSM) Protein Downstream Clients in Global Market
Table 145. Recombinant Human Oncostatin M (OSM) Protein Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Recombinant Human Oncostatin M (OSM) Protein Segment by Purity in 2023
Figure 2. Recombinant Human Oncostatin M (OSM) Protein Segment by Application in 2023
Figure 3. Global Recombinant Human Oncostatin M (OSM) Protein Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Recombinant Human Oncostatin M (OSM) Protein Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Recombinant Human Oncostatin M (OSM) Protein Revenue, 2019-2030 (US$, Mn)
Figure 7. Recombinant Human Oncostatin M (OSM) Protein Sales in Global Market: 2019-2030 (Tons)
Figure 8. The Top 3 and 5 Players Market Share by Recombinant Human Oncostatin M (OSM) Protein Revenue in 2023
Figure 9. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 & 2030
Figure 10. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 11. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 12. By Purity - Global Recombinant Human Oncostatin M (OSM) Protein Price (US$/Ton), 2019-2030
Figure 13. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 & 2030
Figure 14. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 15. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 16. By Application - Global Recombinant Human Oncostatin M (OSM) Protein Price (US$/Ton), 2019-2030
Figure 17. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2023 & 2030
Figure 18. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019 VS 2023 VS 2030
Figure 19. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 20. By Region - Global Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 21. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 22. By Country - North America Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 23. US Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 24. Canada Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 25. Mexico Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 26. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 27. By Country - Europe Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 28. Germany Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 29. France Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 30. U.K. Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 31. Italy Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 32. Russia Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 33. Nordic Countries Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 34. Benelux Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 35. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 36. By Region - Asia Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 37. China Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 38. Japan Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 39. South Korea Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 40. Southeast Asia Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 41. India Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 42. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 43. By Country - South America Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 44. Brazil Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 45. Argentina Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 46. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Revenue Market Share, 2019-2030
Figure 47. By Country - Middle East & Africa Recombinant Human Oncostatin M (OSM) Protein Sales Market Share, 2019-2030
Figure 48. Turkey Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 49. Israel Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 50. Saudi Arabia Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 51. UAE Recombinant Human Oncostatin M (OSM) Protein Revenue, (US$, Mn), 2019-2030
Figure 52. Global Recombinant Human Oncostatin M (OSM) Protein Production Capacity (Tons), 2019-2030
Figure 53. The Percentage of Production Recombinant Human Oncostatin M (OSM) Protein by Region, 2023 VS 2030
Figure 54. Recombinant Human Oncostatin M (OSM) Protein Industry Value Chain
Figure 55. Marketing Channels
